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AbstrACt
Objectives The economic burden of incarceration is 
substantial in Australia. People released from prison are at 
high risk of poor health and this is an important predictor 
of recidivism. The ‘Passports Study’ was a randomised 
controlled trial of an intervention designed to increase 
health service utilisation after release from prison. The aim 
of this study is to conduct a cost–utility analysis of this 
transitional programme.
setting Australia
Design A hybrid simulation model was developed 
to estimate the changes to total economic costs and 
effectiveness expressed as quality-adjusted life-years 
(QALYs) from the adoption of the ’Passports’ intervention 
compared with the control group. Model parameters were 
informed by linked data from Queensland Corrective 
Services, Medicare, Pharmaceutical Benefits Scheme, 
Queensland Hospital Admission Patient Data Collection, 
Emergency Department Information System and National 
Death Index. Health-related quality of life was measured 
using the Short-Form 8 Health Survey (SF-8). The primary 
outcomes were the costs and estimated QALYs associated 
with the intervention group and the control group. 
Probabilistic sensitivity analysis was conducted to test 
parameter uncertainties.
results Compared with the control group where no 
attempt was made to encourage health service utilisation, 
an average participant in the intervention group incurred 
an extra cost of AUD 1790 and experienced slightly 
reduced QALYs, which indicated that the intervention was 
dominated in the baseline analysis. Probabilistic sensitivity 
analysis revealed that the transitional programme had a 
low probability of being cost-effective with the outcome 
measures selected.
Conclusion The findings of this study do not provide 
economic evidence to support the widespread adoption of 
the Passports intervention. Due to the reductionist nature 
of the cost–utility approach, it may be that important 
health-related benefits have been omitted. Another 
research approach using a wider range of health-related 
measures might generate different conclusions.
IntrODuCtIOn  
Australia’s prisoner population reached 
38 845 at 30 June 2016, an increase of 8% 
from 30 June 20 151 and an estimated 51 309 
people were released from prison in Australia 
in 2014.2 At 30 June 2016, at least half the pris-
oners in all states and territories had a history 
of prior imprisonment.1 In Australia, 44.3% 
of prisoners released during 2012–2013 
returned to prison within 2 years of release.3 
In 2014–2015, net operating expenditure 
on corrective services was AUD 3.7 billion.3 
The estimated average cost per prisoner 
per day in 2014–2015 was AUD 301.3 There 
likewise is a huge economic burden from 
criminal activity—it was estimated that the 
cost of crimes represented 4.1% of Austra-
lian national gross domestic product (GDP) 
(AUD 35.8 billion) in 2005.4 
Compared with the non-offending popula-
tion, prisoners have higher rates of chronic 
disease, mental illness, substance depen-
dence and social disadvantage.5–9 According 
to a national survey of prison entrants,232% 
had at least one chronic condition; 49% had 
been told by a doctor that they have a mental 
health disorder; 67% used illicit drugs in the 
previous 12 months; 74% reported being 
current tobacco smokers and 39% consumed 
strengths and limitations of this study
 ► This is the first study ever, globally, to evaluate the 
cost-effectiveness of a transitional programme for 
adults released from prison.
 ► We used linked data to identify recidivism, health 
service utilisation and mortality for a relatively large 
and representative cohort of ex-prisoners.
 ► We developed a decision-analytic model to assess 
the costs and quality of life associated with the tran-
sitional programme.
 ► This study might be limited by the health outcome 
measures used, as other important health-related 
benefits could have been omitted by the cost–utility 
approach.
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alcohol at high risk levels in the past 12 months. Although 
their health might improve while in custody, where 
food, accommodation and low-threshold health services 
are provided at no cost, and where access to drugs is 
limited, recurrence of health impairment and a return 
to previous patterns of risky behaviours after release from 
custody are common.10 11 Moreover, the risk of death is 
higher among ex-prisoners than their community peers, 
particularly during the first few weeks after release.12 A 
study in Australia estimated that the annual number of 
deaths each year within 4 weeks of release from prison 
was greater than the annual number of deaths in custody, 
highlighting the extreme vulnerability of ex-prisoners on 
return to community.13 Among the most common causes 
of death in ex-prisoners are drug overdose, suicide and 
injury12 14 15; however, rates of death due to communicable 
and non-communicable diseases are also elevated.16–18
Given that poor physical and mental health, substance 
abuse and social disadvantage are important predictors of 
recidivism,14 19–21 improving health outcomes for ex-pris-
oners and supporting them in transition from custody 
to community is important from both a public health 
perspective and a criminal justice perspective. Wolitski 
et al22 demonstrated the efficacy of a sexual risk reduc-
tion project that bridges incarceration and commu-
nity re-entry. Friedman et al23 found that collaborative 
behaviour management may reduce substance use among 
parolees, although no difference was seen in total crime 
or re-arrests. The results from another study in the USA 
showed that personalised case management and direct 
monetary support may reduce recidivism in ex-prisoners 
by helping them navigate the re-entry process.24
Although transitional interventions are becoming 
widespread, there is a gap between research and policy.25 
Most evaluations focus on the effectiveness of interven-
tions,22–24 26 27 but little is known about whether those 
interventions represent good value for money or how 
evidence of effectiveness can inform decision making. In 
today’s climate of financial austerity, the great challenge 
for decision-makers is to allocate scarce resources among 
competing demands. Given the already substantial finan-
cial burden associated with incarceration, there might 
be limited political support for costly interventions to 
improve the health of ex-prisoners. Evidence that those 
transitional interventions make economic sense is there-
fore valuable in assisting policymakers who wish to invest 
in improving the health and well-being of this vulnerable 
population.
A single-blinded randomised controlled trial of a 
transitional intervention—the ‘Passports Study’—
was conducted for adult ex-prisoners in Queensland, 
Australia.28 One thousand three hundred and twenty-five 
adults participated in the baseline survey within 6 weeks 
of expected release from custody and were randomised to 
the intervention group or the control group. Participants 
in the intervention group (n=665) received a backpack 
containing a passport-sized booklet tailored to each partic-
ipant, summarising their health status and identifying 
community health services relevant to their health needs. 
Trained workers made weekly telephone contact to the 
intervention group in the first 4 weeks post-release, up 
to a maximum of four calls, to identify health needs 
and encourage participants to access appropriate health 
services. Participants in the control arm (n=660) received 
usual care and a letter providing a brief summary of 
their health status at baseline. Both groups completed 
follow-up interviews 1, 3 and 6 months post their first 
release. For those returned to custody, the follow-up inter-
view was conducted in custody either face to face or by 
telephone. The intervention, which has been described 
in more detail elsewhere,29 significantly increased contact 
with primary care services up to 6 months post-release 
and significantly increased contact with mental health 
services at the 6-month follow-up.30 The ‘Passports’ trial 
was registered with the Australian New Zealand Clinical 
Trials Registry (ACTRN12608000232336).
The aim of this study was to examine the cost-effec-
tiveness of this ‘Passports Study’ to increase contact with 
health services among ex-prisoners in Australia. The 
cost–utility analysis reported here considered how costs 
and health-related outcomes changed with a decision 
to adopt the ‘Passports’ intervention. By presenting the 
cost per unit of health benefit gained, expressed as qual-
ity-adjusted life-years (QALYs), this work will allow deci-
sion-makers to compare this intervention with any other 
use of scarce resources aimed at improving health-related 
outcomes.
MethODs
Patient and public involvement
This study does not involve patients or public.
Cost–utility model
A hybrid simulation model was constructed to compare 
costs and health-related outcomes between the inter-
vention group and the control group. The model had 
the structure of a Markov model but time to event was 
incorporated. The model ran on daily cycles and simu-
lated participants’ movements among four states within 
2 years of release from prison (730 days). Figure 1 shows 
the structure of the model. At the beginning of simu-
lation, all participants were released from prison and 
started from the ‘community’ state. In each day, there was 
a probability that participants could go back to ‘prison’ 
Figure 1 Simulation model structure for evaluating the cost–
utility of ‘Passport Study’.
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if they reoffended or breached supervision conditions, 
or visit ‘emergency department (ED)’, or be admitted to 
‘hospital’, or remain in the ‘community’ state. If partic-
ipants were reincarcerated, they would stay in ‘prison’ 
state for a period of time (time to release) before they 
went back to ‘community’. If participants were hospital-
ised, they would also stay in ‘hospital’ state for a period 
of time (time to separation) before they went back to 
‘community’. It was assumed that participants admitted 
to ‘ED’ was either discharged or transferred to ‘hospital’ 
on the next day. Each state was assigned a cost value and a 
health utility weight, which were accumulated over model 
cycles over time.
Linked data
The data used to parametrise the simulation model were 
sourced from the ‘Passports Study’. Participant identities 
were linked deterministically based on a unique prisoner 
number with data from Queensland Corrective Services 
(QCS) to identify dates of release from custody and 
reincarceration. The unique prisoner number was not 
recorded in State-based records from the Queensland 
Ambulance Service (QAS), Emergency Department Infor-
mation System (EDIS) or Queensland Hospital Admitted 
Patient Data Collection (QHAPDC); or in federal records 
from Medicare Benefits Schedule (MBS, mainly reflecting 
primary care and pathology testing), Pharmaceutical 
Benefits Scheme (PBS) or National Death Index. Thus, 
linkage with these data sets was probabilistic and used all 
known aliases for participants. Participants’ health-related 
quality of life (HRQoL) was assessed at each follow-up 
interview using the Short-Form 8 Health Survey (SF-8) 
that asks one question for each health domain. Linked 
data within 2 years of release from prison (730 days) for 
all individuals were used to derive model inputs.
transition probabilities and time to event
A split Poisson process31 was applied to derive daily transi-
tion probabilities for the three transitions out of commu-
nity. An average rate of transitioning out of community 
was first calculated by dividing the total number of tran-
sitions out of community over 2 years (730 days) by the 
number of individuals. The rate was then converted to a 
daily probability using the formula: P=1–exp(–rate*time). 
The daily probability of a specific event (e.g., hospitalisa-
tion) was calculated by multiplying the daily probability 
of transitioning out of community by the proportion 
of transitions out of community of that event (hospital-
isation). QCS data were used to inform the number of 
reincarcerations and the time to release from prison. 
Numbers of ED visits and hospitalisations were derived 
from EDIS and QHAPDC data, respectively. Time to sepa-
ration from hospital was based on the length of stay in 
QHAPDC data set. The proportion of participants being 
discharged from ED to community or being admitted 
to hospital from ED were informed by participants’ ED 
discharge destinations. The model parameters were 
summarised in table 1.
Costs
For the intervention group, the intervention costs 
included the cost of producing and printing a ‘Health 
Passport’, the cost of a backpack and the cost of four 
intervention calls. Although only a subset of participants 
in the intervention group received all four intervention 
calls when the project was carried out, we assumed that 
everyone received four intervention calls in the model. 






Daily probability of transitioning out of community
  Intervention group 0.0038
  Control group 0.0037
Proportion of transitions out of community
Intervention group
  Reincarceration 0.2929 0.0100 Beta
  Hospitalisation 0.1027 0.0066 Beta
  Emergency 
  department (ED) visit
0.6043 0.0111 Beta
Control group
  Reincarceration 0.3027 0.0101 Beta
  Hospitalisation 0.0835 0.0060 Beta
  ED visit 0.6138 0.0112 Beta
Proportion of hospitalisation following ED
  Intervention group 0.22 0.0124 Beta
  Control group 0.21 0.0122 Beta
Time to release (days)*
  Intervention group 72 5.7618 Gamma
  Control group 64 5.6938 Gamma
Time to separation (days)* 1 0.1958 Gamma
Cost (2013 AUD)
Intervention cost (one-off)
  Intervention group 90 †
  Control group 5 † 
State cost (daily)
  Prison 292 † Gamma
  Hospital 1494.37 27.8413 Gamma
  ED 538.12 6.2375 Gamma
  Community
  Intervention group 4.08 0.2458 Gamma
  Control group 3.48 0.1936 Gamma
Utility
Community
  Intervention group 0.78 0.0070 Beta
  Control group 0.81 0.0059 Beta
Prison
  Intervention group 0.80 0.0279 Beta
  Control group 0.78 0.0413 Beta
*Median value as baseline estimate.
†Aassumed SE was equal to the baseline estimate.
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As participants in the control group received a letter that 
provided a brief summary of their health status when they 
were released from prison, the intervention cost for the 
control group was the cost of producing that letter.
The costs for the ‘community’ state were based on 
information from MBS, PBS and QAS data. The costs 
of Medicare services and medicines were recorded by 
MBS data set and PBS data set, respectively. The cost of 
ambulance attendance was based on gross expenditure 
per incident from the QAS Performance Report 17: 
2013–2014.32 Individuals who returned to prison would 
incur a cost per day in custody.33 Cost per day in ‘hospital’ 
for each individual was based on the Australian refined 
diagnosis-related group (AR-DRG) code associated with 
each hospital admission and informed by AR-DRG cost 
and average length of stay in National Hospital Cost 
Data Collection Australian Public Hospitals Cost Report 
2009–2010, Round 14.34 Costs associated with the ‘ED’ 
state were based on the Urgency Disposition Group 
(UDG) associated with each presentation. National Effi-
cient Price and price weights for each UDG were used to 
calculate ED cost for each individual.35 A health system 
and criminal justice perspective was adopted and all costs 
were reported in 2013 Australian dollars. An annual infla-
tion rate of 5.3% was derived from health expenditure 
index numbers between 2008 and 2013.36 Future costs 
were discounted at a rate of 3%.
sF-8 surveys and quality-adjusted life-years
The effectiveness of the intervention was expressed 
in quality-adjusted life-years (QALYs) which represent 
both duration of life and quality of life. Information 
about the participants’ HRQoL was collected using SF-8 
Health Survey during the follow-up interviews at 1, 3 and 
6 months post their first release. Answers to SF-8 questions 
were mapped onto preference-based Short-Form Six-Di-
mension (SF-6D) utility scores.37 The SF-6D utility score 
provides a single index to describe health state, ranging 
from 0 (worst health state) to 1 (full health). The SF-6D 
utility scores used in this study (table 1) were derived from 
the 557 participants who completed all three follow-up 
health surveys. It was assumed that hospitalisation and 
ED visits were associated with utility decrement of 0.1 
and 0.05, respectively, as there are no reported utility esti-
mates for these transitions. By multiplying SF-6D utility 
score for one health state by the number of years staying 
in that state, QALYs were estimated for cost–utility anal-
ysis. Future QALYs were discounted at a rate of 3%.
Model evaluation
The primary outcome was the incremental cost-effective-
ness ratio (ICER), calculated as the incremental change 
in cost divided by the incremental change in QALY. The 
ICER was considered against a willingness-to-pay threshold 
that shows how much a decision-maker is willing to pay 
for one additional QALY. In Australia, there is no explicit 
threshold beyond which the funding body was unwilling 
to pay for additional life years gained, but researchers 
predicted low probability of recommending coverage 
when the threshold reached round AUD 60 000/QALY.38 
According to an international survey on cost-effective-
ness thresholds, AUD 64 000/QALY was proposed for 
Australia.39 If the intervention group incurred fewer costs 
and reported better QALYs than the control group, the 
intervention would be considered cost saving; if the ICER 
was below the willingness-to-pay threshold of AUD 64 000 
per QALY gained, the intervention would be considered 
cost-effective. If the intervention group incurred more 
costs but was associated with lower QALYs than the control 
group, then the intervention group was dominated by the 
control group.
To capture the uncertainty in model parameter esti-
mates, probabilistic sensitivity analysis was conducted 
to allow parameters to vary probabilistically. Transition 
probabilities and utilities were assigned beta distributions 
and costs were given gamma distributions.40 For cost 
parameters without information on standard deviation 
from the data sets, it was assumed that the standard error 
was equal to the baseline estimate. A total of 5000 random 
simulations were run where a new value was drawn for 
each parameter from the distribution during each simu-
lation. The results of the probabilistic sensitivity analysis 
were used to estimate the probability that the interven-
tion is costeffective as the willingness-to-pay threshold 
varied. This analysis was presented using a cost-effective-
ness plane and cost-effectiveness acceptability curve. All 
analyses were conducted using the statistical software R.41 
R codes and functions are available in online supplemen-
tary appendix 1 and online supplementary appendix 2.
resuLts
Model validity and baseline analysis
Two cohorts of individuals were simulated in the model 
to represent the intervention group (n=665) and 
the control group (n=660), respectively. The simulated 
number of events compared with actual number of events 
are presented in table 2. Overall, the model simulation 
was comparable with the observed data, with consistent 
underestimation of around 7% in both groups.
Total cost and QALY outcomes for the intervention 
group and the control group, along with incremental 
Table 2 Simulated number of events compared with actual 




Simulated number of events
  Intervention 
group
499 402 1029
  Control group 507 354 1028
Actual number of events
  Intervention 
group
539 433 1112
  Control group 544 380 1103
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cost and incremental QALY between the two groups, are 
shown in table 3. Absolute costs for each state, separately 
for participants in the control group and the intervention 
group, are also reported in table 3. The average cost for 
an individual in the intervention group was higher than 
for those in the control group. Estimated mean QALYs 
for participants in the intervention group (1.52) and 
the control group (1.56) were similar. On this basis, it 
appears that the ‘Passport’ intervention is not cost-ef-
fective since it was associated with higher costs and no 
increase in QALYs.
Probabilistic sensitivity analysis
The results of 5000 simulations are presented on a cost-ef-
fectiveness plane (figure 2) where each point represents 
one calculation of incremental cost and incremental 
QALY when model parameters take random values from 
specified probability distributions. Points below the will-
ingness-to-pay threshold line suggest that the interven-
tion is cost-effective. The probability that the intervention 
is cost-effective at certain willingness-to-pay thresholds 
was derived by counting the number of times out of 5000 
that a point lies below the willingness-to-pay line. For the 
willingness-to-pay threshold of AUD 64 000/QALY, the 
probability that the intervention is cost-effective is 43%. 
The probability of being cost-effective for a range of will-
ingness-to-pay thresholds can be summarised in a cost-ef-
fectiveness acceptability curve (as shown in figure 3). 
Figure 3 shows that the intervention group has a lower 
probability (around 33–44%) of being cost-effective 
compared with the intervention, regardless of the value 
of willingness-to-pay threshold.
DIsCussIOn
There are no published studies focusing on the cost-ef-
fectiveness of transitional programmes for prisoners. This 
study examined the ‘Passports Study’, a transitional inter-
vention for ex-prisoners in Australia. A hybrid model was 
developed to simulate recidivism and health service util-
isation over 2 years after study participants were released 
from prison. We observed higher costs in the interven-
tion group and no increase in QALYs, suggesting that the 














  Community $2300.87 $2678.36 $377.50 1.4605 1.4114 −0.0491
  Prison $13 311.05 $14 544.78 $1233.73 0.0978 0.1087 0.0109
  Hospital $777.27 $875.38 $98.11 0.0010 0.0011 0.0001
  Emergency department $813.10 $808.29 -$4.81 0.0031 0.0030 −0.0001
Intervention cost $ 5 $ 90 $85
Total $17 207.29 $18 996.82 $1789.53 1.5625 1.5242 −0.0383
Figure 2 Cost-effectiveness plane for the intervention group over the control group. QALY, quality-adjusted life-year.
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‘Passports’ intervention was not cost-effective using these 
outcome measures. Probabilistic sensitivity analysis was 
conducted to account for uncertainty in the estimates of 
model parameters. The results from a simulation of 5000 
samples suggest that, given AUD 64 000/QALY willing-
ness-to-pay threshold, the ‘Passports’ intervention had 
only a 43% probability of being cost-effective.
Since the proximal aim of the ‘Passports Study’ was 
to increase health service utilisation, it is not surprising 
that healthcare costs were increased. Kinner et al30 found 
that those in the intervention group were more likely to 
report contacting with primary care at 1, 3 and 6 months 
post-release and more likely to report contacting mental 
health services at 6 months post-release. Secondary anal-
yses revealed that early contact with primary care was asso-
ciated with subsequent primary care and mental health 
service contact, ED presentation and hospitalisation.42 
Consistent with this, in the present study, our modelling 
suggested a higher rate of ED presentation and hospital-
isation in the intervention group. Our findings are there-
fore consistent with those of the original trial.
One mechanism by which the Passports intervention 
could have offset the increased costs from greater use of 
health services is by delivering better QALYs; however, our 
modelling based on SF-8 data did not provide evidence for 
this. There are a few possible reasons for this. First, it may 
be that although the intervention increased utilisation of 
health services, this did not translate into better HRQoL 
utility scores. Given the high prevalence of chronic health 
problems, health risk behaviours and entrenched social 
disadvantage in ex-prisoners, contact with mainstream 
health services may be insufficient to achieve better 
HRQoL for this population. Consistent with the ‘inverse 
care law’,43 there is also evidence that the quality of 
healthcare varies in inverse proportion to disadvantage,44 
such that participants in the Passports trial may not have 
accessed the kind of quality care necessary to achieve 
measurable health improvements. One trial in the USA 
found that high-quality, enhanced primary care, targeted 
specifically at the needs of ex-prisoners, was associated 
with reduced ED presentation.45 Future studies of health-
care utilisation in ex-prisoners should attempt to measure 
both the quantity and the quality of care received.
A second reason for the observed findings may relate 
to our proxy for QALYs. QALYs were estimated based on 
SF-6D utility scores, which were in turn estimated from 
SF-8 survey responses. The SF-8 is a self-report measure 
of HRQoL, with questions assessing the perceived impact 
of health states on daily functioning. The Passports inter-
vention involved making participants aware of their 
health-related needs (consistent with the principles of 
motivational interviewing46) and encouraging them to 
access healthcare to have these health needs met. As 
such, the intervention may have made participants more 
cognisant of the ways in which their HRQoL was limited, 
independent of any ‘objective’ measure of health status. 
It seems highly unlikely that the intervention had an 
inverse impact on participant’s ‘objective’ health status. 
Furthermore, SF-6D utility scores were a function of SF-8 
survey responses and only around 40% of participants 
completed each follow-up survey, with loss to follow-up 
associated with health risk behaviours.47 In addition, 
SF-8 survey has not been validated among ex-prisoner/
prisoner populations. Therefore, it is not possible to 
capture the full range of potential health outcomes using 
the SF-8/QALY approach, and in this context, given the 
limitations of our health measure, any conclusions must 
be made with caution. There are also boundaries to the 
value of this approach for decision making48 and another 
research approach, using different data collection tools, 
might generate different insights.
There are some further limitations with this research. 
First, according to the internal validation, the model 
underestimated the number of reincarceration, hospi-
talisation and ED visits in both groups by around 7%. 
This could be caused by the way the model was set up. 
The model was built as a simplified representation of 
real-world process which captures the vital components 
Figure 3 Cost-effectiveness acceptability curve showing the probability of the intervention being cost-effective at varying 
willingness-to-pay thresholds.
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of process for the evaluation, as is typical in model-based 
economic evaluations.49 For example, we assumed in the 
model that once individuals were in the ‘prison’ state they 
could not go to 'hospital’ or ‘ED’. If movement between 
‘prison’ and ‘hospital’/ ‘ED’ is allowed, the ‘prison–
hospital–community’ pathway will be enabled due to the 
memoryless property of model. Thus, some events were 
not captured and the model did not replicate observed 
data exactly. Moreover, the parameterisation of model 
inputs did not take into account individual character-
istics of the participants, but represented the average 
behaviour of the groups instead. As a result, the total 
costs over 2 years could be underestimated and QALYs 
could be overestimated. Second, the method used to map 
SF-8 scores onto the SF-6D has not been validated, unlike 
the SF12 or SF3650; this may have led to either underesti-
mate or overestimate of SF-6D utility scores in our study. 
Third, we derived average HRQoL utility scores based on 
follow-up surveys 1, 3 and 6 months after release, and as 
such may have failed to capture variation in HRQoL over 
more than half of the follow-up time. If increased contact 
with health services in the intervention group improved 
HRQoL only after some time (e.g., by improving manage-
ment of chronic conditions through improved engage-
ment with primary care), this effect may not have been 
captured, and our results would thus underestimate the 
impact of the intervention on HRQoL during the study 
period. Although longitudinal studies with ex-prisoners 
and other vulnerable populations are both challenging 
and resource intensive,51 future studies should consider a 
longer period of follow-up if resources permit.
COnCLusIOn
This study examined a complex policy and research ques-
tion with a wide range of potential economic impacts. The 
findings of this study do not bring economic evidence to 
support the widespread adoption of the Passports inter-
vention, although they also highlight the complexities of 
cost-effectiveness evaluation in this area. Given the limita-
tions in our approach to modelling, further research 
on the potential cost-effectiveness of transitional inter-
ventions for people leaving prison is needed to inform 
evidence-based policy making.
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